BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: d'Abadie P, Hesse M, Louppe A, Lhommel R, Walrand S, Jamar F. Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects. Molecules 2021;26:3966. [PMID: 34209590 DOI: 10.3390/molecules26133966] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 d'Abadie P, Walrand S, Lhommel R, Hesse M, Jamar F. A Theranostic Approach in SIRT: Value of Pre-Therapy Imaging in Treatment Planning. J Clin Med 2022;11. [PMID: 36498819 DOI: 10.3390/jcm11237245] [Reference Citation Analysis]
2 Bodei L, Herrmann K, Schöder H, Scott AM, Lewis JS. Radiotheranostics in oncology: current challenges and emerging opportunities. Nat Rev Clin Oncol 2022. [PMID: 35725926 DOI: 10.1038/s41571-022-00652-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pijeira MSO, Viltres H, Kozempel J, Sakmár M, Vlk M, İlem-Özdemir D, Ekinci M, Srinivasan S, Rajabzadeh AR, Ricci-Junior E, Alencar LMR, Al Qahtani M, Santos-Oliveira R. Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology. EJNMMI Radiopharm Chem 2022;7:8. [PMID: 35467307 DOI: 10.1186/s41181-022-00161-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Kazakov AG, Babenya JS, Ivanova MK, Vinokurov SE, Myasoedov BF. Study of 90Y Sorption with Nanodiamonds as Potential Carriers in the Radiopharmaceutical Composition. Radiochemistry 2022;64:44-8. [DOI: 10.1134/s1066362222010076] [Reference Citation Analysis]
5 d'Abadie P, Walrand S, Lhommel R, Hesse M, Borbath I, Jamar F. Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria. Curr Oncol 2022;29:2422-34. [PMID: 35448170 DOI: 10.3390/curroncol29040196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen H, Teng M, Zhang H, Liang X, Cheng H, Liu G. Advanced radionuclides in diagnosis and therapy for hepatocellular carcinoma. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.03.079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Boni G, Guidoccio F, Volterrani D, Mariani G. Radionuclide Therapy of Tumors of the Liver and Biliary Tract. Nuclear Oncology 2022. [DOI: 10.1007/978-3-319-26067-9_51-2] [Reference Citation Analysis]
8 Cicone F, Gnesin S, Cremonesi M. Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization. Q J Nucl Med Mol Imaging 2021;65:327-32. [PMID: 34881850 DOI: 10.23736/S1824-4785.21.03418-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Filippi L, Braat AJ. Theragnostics in primary and secondary liver tumors: the need for a personalized approach. Q J Nucl Med Mol Imaging 2021;65:353-70. [PMID: 34881847 DOI: 10.23736/S1824-4785.21.03407-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Aramburu J, Antón R, Rodríguez-Fraile M, Sangro B, Bilbao JI. Computational Fluid Dynamics Modeling of Liver Radioembolization: A Review. Cardiovasc Intervent Radiol 2022;45:12-20. [PMID: 34518913 DOI: 10.1007/s00270-021-02956-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]